TSEM

Summary

Staged Buy TSEM drawdown: initiate half position 210-214 around current 213.46 tape, add only on settled daily close above 10-day 212.89 with MACD histogram continuing toward zero. Size to ATR 14.95, stop on settled close below 199.06 (invalidation toward 184-186 confluence of Bollinger lower/200-day). Targets 221-228 congestion first, then 250, stretch 270 Stifel. Use stock or call spreads (avoid outright calls into 77.6% IV), keep size modest into Fear 42.1/oil/war tape. Horizon 5 trading days for alpha vs SPY, thesis extends to forward earnings conversion.

The case

1. Long term uptrend intact, trading 14.7% above the rising long term average near $186, with early bottoming off the lows and improving momentum and RSI recovery. 2. Supported by a $270 sell side Buy catalyst, constructive social sentiment and elevated call activity. 3. Strong operating leverage with revenue up 23.7% to $460M, operating income up 126% with margin near 30%, net cash of $1.48B with improving receivables and inventory, plus more than $320M in deferred prepayments funding capex, while forward earnings de rate the multiple. 4. This outweighs the medium term downtrend below the falling medium term average with momentum still negative, thin news data and single catalyst risk, rich valuation multiples, negative $9.6M free cash flow on $186M capex near 40% of revenue, put overhang and a market fear gauge showing fear, plus 8% overhead to the medium term average. Our analysis sees defined risk near the $186 floor favoring a staged starter rather than a full chase, with asymmetric upside toward $270 with consensus support.

What would weaken it

• Downtrend below falling medium-term average, momentum still negative
• Rich multiples, negative FCF on heavy capex near 40% of revenue
• Thin news, single-catalyst risk with put overhang and macro fear